M. F. Carroll

A practical approach to hypercalcemia.

D. Schade, M. Carroll, M. F. Carroll, 2003, American family physician.

Timing of Antioxidant Vitamin Ingestion Alters Postprandial Proatherogenic Serum Markers

D. Schade, M. Carroll, M. F. Carroll, 2003, Circulation.

The dawn phenomenon revisited: implications for diabetes therapy.

D. Schade, M. F. Carroll, 2005, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.

M. Burge, D. Schade, K. Hardy, 2002, Diabetes technology & therapeutics.

Severe Hypoglycemia in Adults

Mark R. Burge, David S. Schade, M. Burge, 2003, Reviews in Endocrine and Metabolic Disorders.

Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.

D. Schade, M. Carroll, A. Gutierrez, 2003, The Journal of clinical endocrinology and metabolism.

Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.

M. Burge, D. Schade, M. Carroll, 2002, Diabetes care.

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

M. Burge, D. Schade, M. Carroll, 2002, Diabetes care.

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

M. Burge, D. Schade, Ahmad Izard, 2002, Diabetes care.